About Us
Corporate Overview
Executive Leadership
Management team
Scientific Advisory Board
Board of Directors
Clinical Advisory Board
Our Science
Pipeline
Overview
AG-73305
AG-80308
AG-86893
Disease
Overview
DME
nAMD
Other Diseases
Pterygium
Dry Eye
Clinical Trial
Investor Relations
Investors
Press Release & Publications
Allgenesis In The News
Contact Us
Press Release & Publications
Filter by
Categories
Tags
Authors
Show all
All
News
All
2015
2018
2019
2020
2021
2022
2023
All
admin
allgenesis
sky
2021-09-03
Allgenesis Biotherapeutics and AffaMed Therapeutics Announce License Agreement for AG-73305 in Greater China Region
Taipei, Taiwan/ September 3rd, 2021 Allg
[…]
2021-07-15
Allgenesis announces the appointment of Dr. Sunil Patel as Chief Medical Officer
Taipei, Taiwan/ July 15th, 2021 Allgenes
[…]
2020-06-22
Allgenesis Receives Notice of Grant for AG-86893 in Korea and Japan for the Treatment of Pterygium
June 22nd, 2020 Allgenesis Biotherapeuti
[…]
2020-06-08
Allgenesis Receives Notices of Grant of European, Japanese and Taiwan Patent for AG-73305, a Fusion Protein of VEGF Trap and Disintegrin
June 8th, 2020 Allgenesis Biotherapeutic
[…]
2020-05-22
Allgenesis Signs Deal to In-License a Clinical Stage Drug Candidate for Dry Eye Disease
Taipei, Taiwan/ May 22nd, 2020 Allgenesi
[…]
2020-02-20
Dr. Sunil Patel Joins Allgenesis’ Scientific Advisory Board
Taipei, Taiwan/ February 20th, 2020 Allg
[…]
Load more